default author photo

Zhiying Yang

China-Japan Friendship Hospital - Department of Hepatobiliary Surgery

2 Yinghuayuan Dongjie

Beijing, 100029

China

SCHOLARLY PAPERS

3

DOWNLOADS

115

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

A Core-Shell Gold Nanorod@Layered Double Hydroxide Nanomaterial with High Efficient Photothermal Conversion and Its Application in Antibacterial and Tumor Therapy

Number of pages: 34 Posted: 14 Mar 2019
Beijing University of Chemical Technology - State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology - State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology - State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology - State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology - State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology - State Key Laboratory of Chemical Resource Engineering, China-Japan Friendship Hospital - Department of Hepatobiliary Surgery, China-Japan Friendship Hospital - Department of Hepatobiliary Surgery, Chinese Academy of Sciences (CAS) - School of Chemistry and Chemical Engineering and Beijing University of Chemical Technology - State Key Laboratory of Chemical Resource Engineering
Downloads 64 (933,592)
Citation 1

Abstract:

Loading...

gold nanorod, layered double hydroxide, photothermal conversion, antibacterial, tumor therapy

2.

Interferon-Alpha 2b: An Effective Treatment for Hepatic Epithelioid Hemangioendothelioma

Number of pages: 17 Posted: 04 May 2021
Xiaolei Liu and Zhiying Yang
Government of the People's Republic of China - China-Japan Friendship Hospital and China-Japan Friendship Hospital - Department of Hepatobiliary Surgery
Downloads 35 (1,249,711)

Abstract:

Loading...

liver, epithelioid hemangioendothelioma, interferon

3.

Gemcitabine-based chemotherapy plus PD-1/PD-L1 inhibitors and tyrosine kinase inhibitors for initially unresectable intrahepatic cholangiocarcinoma: A multicenter, retrospective cohort study

Number of pages: 37 Posted: 08 Jun 2026
Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, affiliation not provided to SSRN, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhengzhou University, First Affiliated Hospital, Department of Infectious Disease, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Jiaxing University - First Affiliated Hospital, Wenzhou Medical University, Huzhou Central Hospital, China-Japan Friendship Hospital - Department of Hepatobiliary Surgery, Zhejiang University, affiliation not provided to SSRN, Zhejiang Cancer Hospital, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University, affiliation not provided to SSRN, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery and Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery
Downloads 16

Abstract:

Loading...

Intrahepatic cholangiocarcinoma, gemcitabine-based chemotherapy, PD-1/PD-L1 inhibitors, tyrosine kinase inhibitors, outcome.